Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

New England Journal of Medicine - Tập 383 Số 27 - Trang 2603-2615 - 2020
Fernando P. Polack1, Ananda Nisalak1, Nicholas Kitchin1, Judith Absalon1, Alejandra Gurtman1, Stephen Lockhart1, John L. Perez1, Gonzalo Pérez Marc1, Edson Duarte Moreira1, Cristiano A. F. Zerbini1, Ruth Bailey1, Kena A. Swanson1, Satrajit Roychoudhury1, Kenneth Koury1, Ping Li1, Warren V. Kalina1, David Cooper1, Robert W. Frenck1, Marylyn M. Addo1, Özlem Türeci1, Haylene Nell1, Axel Schäfer1, Serhat Ünal1, Dina B. Tresnan1, Susan Mather1, Philip R. Dormitzer1, Uğur Şahin1, Kathrin U. Jansen1, William C. Gruber1
1From Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) — both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S...

Tóm tắt

Từ khóa


Tài liệu tham khảo

Johns Hopkins University Coronavirus Resource Center. COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. 2020 (https://coronavirus.jhu.edu/map.html).

World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 — 11 March 2020 (https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020).

Centers for Disease Control and Prevention. COVID-19 information page (https://www.cdc.gov/coronavirus/2019-ncov/index.html).

10.1056/NEJMoa2027906

10.1016/j.jconrel.2015.08.007

10.1038/mt.2008.200

10.1126/science.abb2507

Sahin U Muik A Vogler I et al. BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans. December 11 2020 (https://www.medrxiv.org/content/10.1101/2020.12.09.20245175v1). preprint.

Food and Drug Administration. Guidance for industry: emergency use authorization for vaccines to prevent COVID-19. October 2020 (https://www.fda.gov/media/142749/download).

10.7326/M20-0504

10.1126/scitranslmed.abe0948

10.1093/cid/ciz1034

Food and Drug Administration. Shringrix (zoster vaccine recombinant adjuvanted) product information. 2019 (https://www.fda.gov/vaccines-blood-biologics/vaccines/shingrix).

Thông tin
Thông tin xuất bản

New England Journal of Medicine

Tập 383 Số 27

2603-2615

Thông tin tác giả